Aricept Complexed with Acetylcholinesterase (Turkish)
From Proteopedia
(Difference between revisions)
| (4 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | <StructureSection load='1eve' size='450' side='right' scene=' | + | <StructureSection load='1eve' size='450' side='right' scene='29/2908/1eve_e20_cartoon/1' caption=''> |
[[Image:E2020_interactins_in_AChE_gorge.jpg|left|250px]]<br /> | [[Image:E2020_interactins_in_AChE_gorge.jpg|left|250px]]<br /> | ||
'''Asetilkolinesteraz ile kompleks oluşturan, anti-Alzheimer ilacı, Aricept’in 3 boyutlu yapısı ''' | '''Asetilkolinesteraz ile kompleks oluşturan, anti-Alzheimer ilacı, Aricept’in 3 boyutlu yapısı ''' | ||
| Line 19: | Line 19: | ||
Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs., Kryger G, Silman I, Sussman JL, Structure. 1999 Mar 15;7(3):297-307. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=10368299 10368299] | Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs., Kryger G, Silman I, Sussman JL, Structure. 1999 Mar 15;7(3):297-307. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=10368299 10368299] | ||
| - | + | [[ar:Aricept_Complexed_with_Acetylcholinesterase (Arabic)]] | |
| + | [[ca:Aricept_Complexed_with_Acetylcholinesterase (Catalan)]] | ||
| + | [[zh:Aricept_Complexed_with_Acetylcholinesterase (Chinese)]] | ||
| + | [[cs:Aricept_Complexed_with_Acetylcholinesterase (Czech)]] | ||
| + | [[de:Aricept_Complexed_with_Acetylcholinesterase (German)]] | ||
| + | [[en:Aricept_Complexed_with_Acetylcholinesterase]] | ||
| + | [[es:Aricept_Complexed_with_Acetylcholinesterase (Spanish)]] | ||
| + | [[fr:Aricept_Complexed_with_Acetylcholinesterase (French)]] | ||
| + | [[he:Aricept_Complexed_with_Acetylcholinesterase (Hebrew)]] | ||
| + | [[it:Aricept_Complexed_with_Acetylcholinesterase (Italian)]] | ||
| + | [[ru:Aricept_Complexed_with_Acetylcholinesterase (Russian)]] | ||
| + | [[sk:Aricept_Complexed_with_Acetylcholinesterase (Slovak)]] | ||
| + | [[vi:Aricept_Complexed_with_Acetylcholinesterase (Vietnamese)]] | ||
| + | [[tr:Aricept_Complexed_with_Acetylcholinesterase (Turkish)]] | ||
| - | [[ar:1eve (Arabic)]] | ||
| - | [[zh:1eve (Chinese)]] | ||
| - | [[fr:1eve (French)]] | ||
| - | [[de:1eve (German)]] | ||
| - | [[ru:1eve (Russian)]] | ||
| - | [[es:1eve (Spanish)]] | ||
| - | [[tr:1eve (Turkish)]] | ||
| - | [[he:1eve (Hebrew)]] | ||
| - | [[it:1eve (Italian)]] | ||
[[Category: Acetylcholinesterase]] | [[Category: Acetylcholinesterase]] | ||
Current revision
| |||||||||||
Kaynak
Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs., Kryger G, Silman I, Sussman JL, Structure. 1999 Mar 15;7(3):297-307. PMID:10368299
Proteopedia Page Contributors and Editors (what is this?)
Samet Serdar Yildirim, Jaime Prilusky, Alexander Berchansky, Joel L. Sussman, Sezen Balli, Fred Vellieux, Eran Hodis
